Drugs / SVF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03939741 | Apr 2019 → Mar 2024 | chronic kidney disease | Bangladesh Laser & Cell Surgery Institute & Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03939741 ↗ |
| Modality | Cell therapy | “SVF (Adipose Tissue Derived MSC) Based Therapy” NCT03939741 ↗ |
| Route | Intravenous | “will be injected intravenously” NCT03939741 ↗ |